Global Contact-Activated Lancet Market Growth 2026-2032
The global Contact-Activated Lancet market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Contact-activated lancets, also called finger sticks, are done using a device called a lancet. Lancets are needles or narrow, sharp blades that poke a small hole in the skin.
United States market for Contact-Activated Lancet is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Contact-Activated Lancet is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Contact-Activated Lancet is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Contact-Activated Lancet players cover BD, Accu-Chek (Roche), OneTouch (LifeScan), FreeStyle (Abbott), Microlet Next (Ascensia), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Contact-Activated Lancet Industry Forecast” looks at past sales and reviews total world Contact-Activated Lancet sales in 2025, providing a comprehensive analysis by region and market sector of projected Contact-Activated Lancet sales for 2026 through 2032. With Contact-Activated Lancet sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Contact-Activated Lancet industry.
This Insight Report provides a comprehensive analysis of the global Contact-Activated Lancet landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Contact-Activated Lancet portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Contact-Activated Lancet market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Contact-Activated Lancet and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Contact-Activated Lancet.
This report presents a comprehensive overview, market shares, and growth opportunities of Contact-Activated Lancet market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Contact-activated lancets, also called finger sticks, are done using a device called a lancet. Lancets are needles or narrow, sharp blades that poke a small hole in the skin.
United States market for Contact-Activated Lancet is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Contact-Activated Lancet is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Contact-Activated Lancet is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Contact-Activated Lancet players cover BD, Accu-Chek (Roche), OneTouch (LifeScan), FreeStyle (Abbott), Microlet Next (Ascensia), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Contact-Activated Lancet Industry Forecast” looks at past sales and reviews total world Contact-Activated Lancet sales in 2025, providing a comprehensive analysis by region and market sector of projected Contact-Activated Lancet sales for 2026 through 2032. With Contact-Activated Lancet sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Contact-Activated Lancet industry.
This Insight Report provides a comprehensive analysis of the global Contact-Activated Lancet landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Contact-Activated Lancet portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Contact-Activated Lancet market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Contact-Activated Lancet and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Contact-Activated Lancet.
This report presents a comprehensive overview, market shares, and growth opportunities of Contact-Activated Lancet market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Below 30G
- Above 30G
- Hospital
- Clinic
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- BD
- Accu-Chek (Roche)
- OneTouch (LifeScan)
- FreeStyle (Abbott)
- Microlet Next (Ascensia)
- Terumo
- Genteel
- CareTouch
- Pip Diabetes Care
- Owen Mumford
- Trividia Health
- AUVON
- What is the 10-year outlook for the global Contact-Activated Lancet market?
- What factors are driving Contact-Activated Lancet market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Contact-Activated Lancet market opportunities vary by end market size?
- How does Contact-Activated Lancet break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Contact-Activated Lancet Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Contact-Activated Lancet by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Contact-Activated Lancet by Country/Region, 2021, 2025 & 2032
2.2 Contact-Activated Lancet Segment by Type
2.2.1 Below 30G
2.2.2 Above 30G
2.2.3 Contact-Activated Lancet Sales by Type
2.2.3.1 Global Contact-Activated Lancet Sales Market Share by Type (2021-2026)
2.2.3.2 Global Contact-Activated Lancet Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Contact-Activated Lancet Sale Price by Type (2021-2026)
2.3 Contact-Activated Lancet Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Others
2.3.4 Contact-Activated Lancet Sales by Application
2.3.4.1 Global Contact-Activated Lancet Sale Market Share by Application (2021-2026)
2.3.4.2 Global Contact-Activated Lancet Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Contact-Activated Lancet Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Contact-Activated Lancet Breakdown Data by Company
3.1.1 Global Contact-Activated Lancet Annual Sales by Company (2021-2026)
3.1.2 Global Contact-Activated Lancet Sales Market Share by Company (2021-2026)
3.2 Global Contact-Activated Lancet Annual Revenue by Company (2021-2026)
3.2.1 Global Contact-Activated Lancet Revenue by Company (2021-2026)
3.2.2 Global Contact-Activated Lancet Revenue Market Share by Company (2021-2026)
3.3 Global Contact-Activated Lancet Sale Price by Company
3.4 Key Manufacturers Contact-Activated Lancet Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Contact-Activated Lancet Product Location Distribution
3.4.2 Players Contact-Activated Lancet Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CONTACT-ACTIVATED LANCET BY GEOGRAPHIC REGION
4.1 World Historic Contact-Activated Lancet Market Size by Geographic Region (2021-2026)
4.1.1 Global Contact-Activated Lancet Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Contact-Activated Lancet Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Contact-Activated Lancet Market Size by Country/Region (2021-2026)
4.2.1 Global Contact-Activated Lancet Annual Sales by Country/Region (2021-2026)
4.2.2 Global Contact-Activated Lancet Annual Revenue by Country/Region (2021-2026)
4.3 Americas Contact-Activated Lancet Sales Growth
4.4 APAC Contact-Activated Lancet Sales Growth
4.5 Europe Contact-Activated Lancet Sales Growth
4.6 Middle East & Africa Contact-Activated Lancet Sales Growth
5 AMERICAS
5.1 Americas Contact-Activated Lancet Sales by Country
5.1.1 Americas Contact-Activated Lancet Sales by Country (2021-2026)
5.1.2 Americas Contact-Activated Lancet Revenue by Country (2021-2026)
5.2 Americas Contact-Activated Lancet Sales by Type (2021-2026)
5.3 Americas Contact-Activated Lancet Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Contact-Activated Lancet Sales by Region
6.1.1 APAC Contact-Activated Lancet Sales by Region (2021-2026)
6.1.2 APAC Contact-Activated Lancet Revenue by Region (2021-2026)
6.2 APAC Contact-Activated Lancet Sales by Type (2021-2026)
6.3 APAC Contact-Activated Lancet Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Contact-Activated Lancet by Country
7.1.1 Europe Contact-Activated Lancet Sales by Country (2021-2026)
7.1.2 Europe Contact-Activated Lancet Revenue by Country (2021-2026)
7.2 Europe Contact-Activated Lancet Sales by Type (2021-2026)
7.3 Europe Contact-Activated Lancet Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Contact-Activated Lancet by Country
8.1.1 Middle East & Africa Contact-Activated Lancet Sales by Country (2021-2026)
8.1.2 Middle East & Africa Contact-Activated Lancet Revenue by Country (2021-2026)
8.2 Middle East & Africa Contact-Activated Lancet Sales by Type (2021-2026)
8.3 Middle East & Africa Contact-Activated Lancet Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Contact-Activated Lancet
10.3 Manufacturing Process Analysis of Contact-Activated Lancet
10.4 Industry Chain Structure of Contact-Activated Lancet
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Contact-Activated Lancet Distributors
11.3 Contact-Activated Lancet Customer
12 WORLD FORECAST REVIEW FOR CONTACT-ACTIVATED LANCET BY GEOGRAPHIC REGION
12.1 Global Contact-Activated Lancet Market Size Forecast by Region
12.1.1 Global Contact-Activated Lancet Forecast by Region (2027-2032)
12.1.2 Global Contact-Activated Lancet Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Contact-Activated Lancet Forecast by Type (2027-2032)
12.7 Global Contact-Activated Lancet Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 BD
13.1.1 BD Company Information
13.1.2 BD Contact-Activated Lancet Product Portfolios and Specifications
13.1.3 BD Contact-Activated Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 BD Main Business Overview
13.1.5 BD Latest Developments
13.2 Accu-Chek (Roche)
13.2.1 Accu-Chek (Roche) Company Information
13.2.2 Accu-Chek (Roche) Contact-Activated Lancet Product Portfolios and Specifications
13.2.3 Accu-Chek (Roche) Contact-Activated Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Accu-Chek (Roche) Main Business Overview
13.2.5 Accu-Chek (Roche) Latest Developments
13.3 OneTouch (LifeScan)
13.3.1 OneTouch (LifeScan) Company Information
13.3.2 OneTouch (LifeScan) Contact-Activated Lancet Product Portfolios and Specifications
13.3.3 OneTouch (LifeScan) Contact-Activated Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 OneTouch (LifeScan) Main Business Overview
13.3.5 OneTouch (LifeScan) Latest Developments
13.4 FreeStyle (Abbott)
13.4.1 FreeStyle (Abbott) Company Information
13.4.2 FreeStyle (Abbott) Contact-Activated Lancet Product Portfolios and Specifications
13.4.3 FreeStyle (Abbott) Contact-Activated Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 FreeStyle (Abbott) Main Business Overview
13.4.5 FreeStyle (Abbott) Latest Developments
13.5 Microlet Next (Ascensia)
13.5.1 Microlet Next (Ascensia) Company Information
13.5.2 Microlet Next (Ascensia) Contact-Activated Lancet Product Portfolios and Specifications
13.5.3 Microlet Next (Ascensia) Contact-Activated Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Microlet Next (Ascensia) Main Business Overview
13.5.5 Microlet Next (Ascensia) Latest Developments
13.6 Terumo
13.6.1 Terumo Company Information
13.6.2 Terumo Contact-Activated Lancet Product Portfolios and Specifications
13.6.3 Terumo Contact-Activated Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Terumo Main Business Overview
13.6.5 Terumo Latest Developments
13.7 Genteel
13.7.1 Genteel Company Information
13.7.2 Genteel Contact-Activated Lancet Product Portfolios and Specifications
13.7.3 Genteel Contact-Activated Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Genteel Main Business Overview
13.7.5 Genteel Latest Developments
13.8 CareTouch
13.8.1 CareTouch Company Information
13.8.2 CareTouch Contact-Activated Lancet Product Portfolios and Specifications
13.8.3 CareTouch Contact-Activated Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 CareTouch Main Business Overview
13.8.5 CareTouch Latest Developments
13.9 Pip Diabetes Care
13.9.1 Pip Diabetes Care Company Information
13.9.2 Pip Diabetes Care Contact-Activated Lancet Product Portfolios and Specifications
13.9.3 Pip Diabetes Care Contact-Activated Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Pip Diabetes Care Main Business Overview
13.9.5 Pip Diabetes Care Latest Developments
13.10 Owen Mumford
13.10.1 Owen Mumford Company Information
13.10.2 Owen Mumford Contact-Activated Lancet Product Portfolios and Specifications
13.10.3 Owen Mumford Contact-Activated Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Owen Mumford Main Business Overview
13.10.5 Owen Mumford Latest Developments
13.11 Trividia Health
13.11.1 Trividia Health Company Information
13.11.2 Trividia Health Contact-Activated Lancet Product Portfolios and Specifications
13.11.3 Trividia Health Contact-Activated Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Trividia Health Main Business Overview
13.11.5 Trividia Health Latest Developments
13.12 AUVON
13.12.1 AUVON Company Information
13.12.2 AUVON Contact-Activated Lancet Product Portfolios and Specifications
13.12.3 AUVON Contact-Activated Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 AUVON Main Business Overview
13.12.5 AUVON Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Contact-Activated Lancet Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Contact-Activated Lancet by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Contact-Activated Lancet by Country/Region, 2021, 2025 & 2032
2.2 Contact-Activated Lancet Segment by Type
2.2.1 Below 30G
2.2.2 Above 30G
2.2.3 Contact-Activated Lancet Sales by Type
2.2.3.1 Global Contact-Activated Lancet Sales Market Share by Type (2021-2026)
2.2.3.2 Global Contact-Activated Lancet Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Contact-Activated Lancet Sale Price by Type (2021-2026)
2.3 Contact-Activated Lancet Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Others
2.3.4 Contact-Activated Lancet Sales by Application
2.3.4.1 Global Contact-Activated Lancet Sale Market Share by Application (2021-2026)
2.3.4.2 Global Contact-Activated Lancet Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Contact-Activated Lancet Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Contact-Activated Lancet Breakdown Data by Company
3.1.1 Global Contact-Activated Lancet Annual Sales by Company (2021-2026)
3.1.2 Global Contact-Activated Lancet Sales Market Share by Company (2021-2026)
3.2 Global Contact-Activated Lancet Annual Revenue by Company (2021-2026)
3.2.1 Global Contact-Activated Lancet Revenue by Company (2021-2026)
3.2.2 Global Contact-Activated Lancet Revenue Market Share by Company (2021-2026)
3.3 Global Contact-Activated Lancet Sale Price by Company
3.4 Key Manufacturers Contact-Activated Lancet Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Contact-Activated Lancet Product Location Distribution
3.4.2 Players Contact-Activated Lancet Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CONTACT-ACTIVATED LANCET BY GEOGRAPHIC REGION
4.1 World Historic Contact-Activated Lancet Market Size by Geographic Region (2021-2026)
4.1.1 Global Contact-Activated Lancet Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Contact-Activated Lancet Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Contact-Activated Lancet Market Size by Country/Region (2021-2026)
4.2.1 Global Contact-Activated Lancet Annual Sales by Country/Region (2021-2026)
4.2.2 Global Contact-Activated Lancet Annual Revenue by Country/Region (2021-2026)
4.3 Americas Contact-Activated Lancet Sales Growth
4.4 APAC Contact-Activated Lancet Sales Growth
4.5 Europe Contact-Activated Lancet Sales Growth
4.6 Middle East & Africa Contact-Activated Lancet Sales Growth
5 AMERICAS
5.1 Americas Contact-Activated Lancet Sales by Country
5.1.1 Americas Contact-Activated Lancet Sales by Country (2021-2026)
5.1.2 Americas Contact-Activated Lancet Revenue by Country (2021-2026)
5.2 Americas Contact-Activated Lancet Sales by Type (2021-2026)
5.3 Americas Contact-Activated Lancet Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Contact-Activated Lancet Sales by Region
6.1.1 APAC Contact-Activated Lancet Sales by Region (2021-2026)
6.1.2 APAC Contact-Activated Lancet Revenue by Region (2021-2026)
6.2 APAC Contact-Activated Lancet Sales by Type (2021-2026)
6.3 APAC Contact-Activated Lancet Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Contact-Activated Lancet by Country
7.1.1 Europe Contact-Activated Lancet Sales by Country (2021-2026)
7.1.2 Europe Contact-Activated Lancet Revenue by Country (2021-2026)
7.2 Europe Contact-Activated Lancet Sales by Type (2021-2026)
7.3 Europe Contact-Activated Lancet Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Contact-Activated Lancet by Country
8.1.1 Middle East & Africa Contact-Activated Lancet Sales by Country (2021-2026)
8.1.2 Middle East & Africa Contact-Activated Lancet Revenue by Country (2021-2026)
8.2 Middle East & Africa Contact-Activated Lancet Sales by Type (2021-2026)
8.3 Middle East & Africa Contact-Activated Lancet Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Contact-Activated Lancet
10.3 Manufacturing Process Analysis of Contact-Activated Lancet
10.4 Industry Chain Structure of Contact-Activated Lancet
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Contact-Activated Lancet Distributors
11.3 Contact-Activated Lancet Customer
12 WORLD FORECAST REVIEW FOR CONTACT-ACTIVATED LANCET BY GEOGRAPHIC REGION
12.1 Global Contact-Activated Lancet Market Size Forecast by Region
12.1.1 Global Contact-Activated Lancet Forecast by Region (2027-2032)
12.1.2 Global Contact-Activated Lancet Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Contact-Activated Lancet Forecast by Type (2027-2032)
12.7 Global Contact-Activated Lancet Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 BD
13.1.1 BD Company Information
13.1.2 BD Contact-Activated Lancet Product Portfolios and Specifications
13.1.3 BD Contact-Activated Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 BD Main Business Overview
13.1.5 BD Latest Developments
13.2 Accu-Chek (Roche)
13.2.1 Accu-Chek (Roche) Company Information
13.2.2 Accu-Chek (Roche) Contact-Activated Lancet Product Portfolios and Specifications
13.2.3 Accu-Chek (Roche) Contact-Activated Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Accu-Chek (Roche) Main Business Overview
13.2.5 Accu-Chek (Roche) Latest Developments
13.3 OneTouch (LifeScan)
13.3.1 OneTouch (LifeScan) Company Information
13.3.2 OneTouch (LifeScan) Contact-Activated Lancet Product Portfolios and Specifications
13.3.3 OneTouch (LifeScan) Contact-Activated Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 OneTouch (LifeScan) Main Business Overview
13.3.5 OneTouch (LifeScan) Latest Developments
13.4 FreeStyle (Abbott)
13.4.1 FreeStyle (Abbott) Company Information
13.4.2 FreeStyle (Abbott) Contact-Activated Lancet Product Portfolios and Specifications
13.4.3 FreeStyle (Abbott) Contact-Activated Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 FreeStyle (Abbott) Main Business Overview
13.4.5 FreeStyle (Abbott) Latest Developments
13.5 Microlet Next (Ascensia)
13.5.1 Microlet Next (Ascensia) Company Information
13.5.2 Microlet Next (Ascensia) Contact-Activated Lancet Product Portfolios and Specifications
13.5.3 Microlet Next (Ascensia) Contact-Activated Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Microlet Next (Ascensia) Main Business Overview
13.5.5 Microlet Next (Ascensia) Latest Developments
13.6 Terumo
13.6.1 Terumo Company Information
13.6.2 Terumo Contact-Activated Lancet Product Portfolios and Specifications
13.6.3 Terumo Contact-Activated Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Terumo Main Business Overview
13.6.5 Terumo Latest Developments
13.7 Genteel
13.7.1 Genteel Company Information
13.7.2 Genteel Contact-Activated Lancet Product Portfolios and Specifications
13.7.3 Genteel Contact-Activated Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Genteel Main Business Overview
13.7.5 Genteel Latest Developments
13.8 CareTouch
13.8.1 CareTouch Company Information
13.8.2 CareTouch Contact-Activated Lancet Product Portfolios and Specifications
13.8.3 CareTouch Contact-Activated Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 CareTouch Main Business Overview
13.8.5 CareTouch Latest Developments
13.9 Pip Diabetes Care
13.9.1 Pip Diabetes Care Company Information
13.9.2 Pip Diabetes Care Contact-Activated Lancet Product Portfolios and Specifications
13.9.3 Pip Diabetes Care Contact-Activated Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Pip Diabetes Care Main Business Overview
13.9.5 Pip Diabetes Care Latest Developments
13.10 Owen Mumford
13.10.1 Owen Mumford Company Information
13.10.2 Owen Mumford Contact-Activated Lancet Product Portfolios and Specifications
13.10.3 Owen Mumford Contact-Activated Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Owen Mumford Main Business Overview
13.10.5 Owen Mumford Latest Developments
13.11 Trividia Health
13.11.1 Trividia Health Company Information
13.11.2 Trividia Health Contact-Activated Lancet Product Portfolios and Specifications
13.11.3 Trividia Health Contact-Activated Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Trividia Health Main Business Overview
13.11.5 Trividia Health Latest Developments
13.12 AUVON
13.12.1 AUVON Company Information
13.12.2 AUVON Contact-Activated Lancet Product Portfolios and Specifications
13.12.3 AUVON Contact-Activated Lancet Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 AUVON Main Business Overview
13.12.5 AUVON Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Contact-Activated Lancet Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Contact-Activated Lancet Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Below 30G
Table 4. Major Players of Above 30G
Table 5. Global Contact-Activated Lancet Sales by Type (2021-2026) & (K Units)
Table 6. Global Contact-Activated Lancet Sales Market Share by Type (2021-2026)
Table 7. Global Contact-Activated Lancet Revenue by Type (2021-2026) & ($ million)
Table 8. Global Contact-Activated Lancet Revenue Market Share by Type (2021-2026)
Table 9. Global Contact-Activated Lancet Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Contact-Activated Lancet Sale by Application (2021-2026) & (K Units)
Table 11. Global Contact-Activated Lancet Sale Market Share by Application (2021-2026)
Table 12. Global Contact-Activated Lancet Revenue by Application (2021-2026) & ($ million)
Table 13. Global Contact-Activated Lancet Revenue Market Share by Application (2021-2026)
Table 14. Global Contact-Activated Lancet Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Contact-Activated Lancet Sales by Company (2021-2026) & (K Units)
Table 16. Global Contact-Activated Lancet Sales Market Share by Company (2021-2026)
Table 17. Global Contact-Activated Lancet Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Contact-Activated Lancet Revenue Market Share by Company (2021-2026)
Table 19. Global Contact-Activated Lancet Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Contact-Activated Lancet Producing Area Distribution and Sales Area
Table 21. Players Contact-Activated Lancet Products Offered
Table 22. Contact-Activated Lancet Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Contact-Activated Lancet Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Contact-Activated Lancet Sales Market Share Geographic Region (2021-2026)
Table 27. Global Contact-Activated Lancet Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Contact-Activated Lancet Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Contact-Activated Lancet Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Contact-Activated Lancet Sales Market Share by Country/Region (2021-2026)
Table 31. Global Contact-Activated Lancet Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Contact-Activated Lancet Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Contact-Activated Lancet Sales by Country (2021-2026) & (K Units)
Table 34. Americas Contact-Activated Lancet Sales Market Share by Country (2021-2026)
Table 35. Americas Contact-Activated Lancet Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Contact-Activated Lancet Sales by Type (2021-2026) & (K Units)
Table 37. Americas Contact-Activated Lancet Sales by Application (2021-2026) & (K Units)
Table 38. APAC Contact-Activated Lancet Sales by Region (2021-2026) & (K Units)
Table 39. APAC Contact-Activated Lancet Sales Market Share by Region (2021-2026)
Table 40. APAC Contact-Activated Lancet Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Contact-Activated Lancet Sales by Type (2021-2026) & (K Units)
Table 42. APAC Contact-Activated Lancet Sales by Application (2021-2026) & (K Units)
Table 43. Europe Contact-Activated Lancet Sales by Country (2021-2026) & (K Units)
Table 44. Europe Contact-Activated Lancet Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Contact-Activated Lancet Sales by Type (2021-2026) & (K Units)
Table 46. Europe Contact-Activated Lancet Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Contact-Activated Lancet Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Contact-Activated Lancet Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Contact-Activated Lancet Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Contact-Activated Lancet Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Contact-Activated Lancet
Table 52. Key Market Challenges & Risks of Contact-Activated Lancet
Table 53. Key Industry Trends of Contact-Activated Lancet
Table 54. Contact-Activated Lancet Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Contact-Activated Lancet Distributors List
Table 57. Contact-Activated Lancet Customer List
Table 58. Global Contact-Activated Lancet Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Contact-Activated Lancet Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Contact-Activated Lancet Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Contact-Activated Lancet Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Contact-Activated Lancet Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Contact-Activated Lancet Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Contact-Activated Lancet Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Contact-Activated Lancet Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Contact-Activated Lancet Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Contact-Activated Lancet Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Contact-Activated Lancet Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Contact-Activated Lancet Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Contact-Activated Lancet Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Contact-Activated Lancet Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. BD Basic Information, Contact-Activated Lancet Manufacturing Base, Sales Area and Its Competitors
Table 73. BD Contact-Activated Lancet Product Portfolios and Specifications
Table 74. BD Contact-Activated Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. BD Main Business
Table 76. BD Latest Developments
Table 77. Accu-Chek (Roche) Basic Information, Contact-Activated Lancet Manufacturing Base, Sales Area and Its Competitors
Table 78. Accu-Chek (Roche) Contact-Activated Lancet Product Portfolios and Specifications
Table 79. Accu-Chek (Roche) Contact-Activated Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Accu-Chek (Roche) Main Business
Table 81. Accu-Chek (Roche) Latest Developments
Table 82. OneTouch (LifeScan) Basic Information, Contact-Activated Lancet Manufacturing Base, Sales Area and Its Competitors
Table 83. OneTouch (LifeScan) Contact-Activated Lancet Product Portfolios and Specifications
Table 84. OneTouch (LifeScan) Contact-Activated Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. OneTouch (LifeScan) Main Business
Table 86. OneTouch (LifeScan) Latest Developments
Table 87. FreeStyle (Abbott) Basic Information, Contact-Activated Lancet Manufacturing Base, Sales Area and Its Competitors
Table 88. FreeStyle (Abbott) Contact-Activated Lancet Product Portfolios and Specifications
Table 89. FreeStyle (Abbott) Contact-Activated Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. FreeStyle (Abbott) Main Business
Table 91. FreeStyle (Abbott) Latest Developments
Table 92. Microlet Next (Ascensia) Basic Information, Contact-Activated Lancet Manufacturing Base, Sales Area and Its Competitors
Table 93. Microlet Next (Ascensia) Contact-Activated Lancet Product Portfolios and Specifications
Table 94. Microlet Next (Ascensia) Contact-Activated Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Microlet Next (Ascensia) Main Business
Table 96. Microlet Next (Ascensia) Latest Developments
Table 97. Terumo Basic Information, Contact-Activated Lancet Manufacturing Base, Sales Area and Its Competitors
Table 98. Terumo Contact-Activated Lancet Product Portfolios and Specifications
Table 99. Terumo Contact-Activated Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Terumo Main Business
Table 101. Terumo Latest Developments
Table 102. Genteel Basic Information, Contact-Activated Lancet Manufacturing Base, Sales Area and Its Competitors
Table 103. Genteel Contact-Activated Lancet Product Portfolios and Specifications
Table 104. Genteel Contact-Activated Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Genteel Main Business
Table 106. Genteel Latest Developments
Table 107. CareTouch Basic Information, Contact-Activated Lancet Manufacturing Base, Sales Area and Its Competitors
Table 108. CareTouch Contact-Activated Lancet Product Portfolios and Specifications
Table 109. CareTouch Contact-Activated Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. CareTouch Main Business
Table 111. CareTouch Latest Developments
Table 112. Pip Diabetes Care Basic Information, Contact-Activated Lancet Manufacturing Base, Sales Area and Its Competitors
Table 113. Pip Diabetes Care Contact-Activated Lancet Product Portfolios and Specifications
Table 114. Pip Diabetes Care Contact-Activated Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Pip Diabetes Care Main Business
Table 116. Pip Diabetes Care Latest Developments
Table 117. Owen Mumford Basic Information, Contact-Activated Lancet Manufacturing Base, Sales Area and Its Competitors
Table 118. Owen Mumford Contact-Activated Lancet Product Portfolios and Specifications
Table 119. Owen Mumford Contact-Activated Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Owen Mumford Main Business
Table 121. Owen Mumford Latest Developments
Table 122. Trividia Health Basic Information, Contact-Activated Lancet Manufacturing Base, Sales Area and Its Competitors
Table 123. Trividia Health Contact-Activated Lancet Product Portfolios and Specifications
Table 124. Trividia Health Contact-Activated Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Trividia Health Main Business
Table 126. Trividia Health Latest Developments
Table 127. AUVON Basic Information, Contact-Activated Lancet Manufacturing Base, Sales Area and Its Competitors
Table 128. AUVON Contact-Activated Lancet Product Portfolios and Specifications
Table 129. AUVON Contact-Activated Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. AUVON Main Business
Table 131. AUVON Latest Developments
Table 1. Contact-Activated Lancet Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Contact-Activated Lancet Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Below 30G
Table 4. Major Players of Above 30G
Table 5. Global Contact-Activated Lancet Sales by Type (2021-2026) & (K Units)
Table 6. Global Contact-Activated Lancet Sales Market Share by Type (2021-2026)
Table 7. Global Contact-Activated Lancet Revenue by Type (2021-2026) & ($ million)
Table 8. Global Contact-Activated Lancet Revenue Market Share by Type (2021-2026)
Table 9. Global Contact-Activated Lancet Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Contact-Activated Lancet Sale by Application (2021-2026) & (K Units)
Table 11. Global Contact-Activated Lancet Sale Market Share by Application (2021-2026)
Table 12. Global Contact-Activated Lancet Revenue by Application (2021-2026) & ($ million)
Table 13. Global Contact-Activated Lancet Revenue Market Share by Application (2021-2026)
Table 14. Global Contact-Activated Lancet Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Contact-Activated Lancet Sales by Company (2021-2026) & (K Units)
Table 16. Global Contact-Activated Lancet Sales Market Share by Company (2021-2026)
Table 17. Global Contact-Activated Lancet Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Contact-Activated Lancet Revenue Market Share by Company (2021-2026)
Table 19. Global Contact-Activated Lancet Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Contact-Activated Lancet Producing Area Distribution and Sales Area
Table 21. Players Contact-Activated Lancet Products Offered
Table 22. Contact-Activated Lancet Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Contact-Activated Lancet Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Contact-Activated Lancet Sales Market Share Geographic Region (2021-2026)
Table 27. Global Contact-Activated Lancet Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Contact-Activated Lancet Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Contact-Activated Lancet Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Contact-Activated Lancet Sales Market Share by Country/Region (2021-2026)
Table 31. Global Contact-Activated Lancet Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Contact-Activated Lancet Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Contact-Activated Lancet Sales by Country (2021-2026) & (K Units)
Table 34. Americas Contact-Activated Lancet Sales Market Share by Country (2021-2026)
Table 35. Americas Contact-Activated Lancet Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Contact-Activated Lancet Sales by Type (2021-2026) & (K Units)
Table 37. Americas Contact-Activated Lancet Sales by Application (2021-2026) & (K Units)
Table 38. APAC Contact-Activated Lancet Sales by Region (2021-2026) & (K Units)
Table 39. APAC Contact-Activated Lancet Sales Market Share by Region (2021-2026)
Table 40. APAC Contact-Activated Lancet Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Contact-Activated Lancet Sales by Type (2021-2026) & (K Units)
Table 42. APAC Contact-Activated Lancet Sales by Application (2021-2026) & (K Units)
Table 43. Europe Contact-Activated Lancet Sales by Country (2021-2026) & (K Units)
Table 44. Europe Contact-Activated Lancet Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Contact-Activated Lancet Sales by Type (2021-2026) & (K Units)
Table 46. Europe Contact-Activated Lancet Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Contact-Activated Lancet Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Contact-Activated Lancet Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Contact-Activated Lancet Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Contact-Activated Lancet Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Contact-Activated Lancet
Table 52. Key Market Challenges & Risks of Contact-Activated Lancet
Table 53. Key Industry Trends of Contact-Activated Lancet
Table 54. Contact-Activated Lancet Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Contact-Activated Lancet Distributors List
Table 57. Contact-Activated Lancet Customer List
Table 58. Global Contact-Activated Lancet Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Contact-Activated Lancet Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Contact-Activated Lancet Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Contact-Activated Lancet Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Contact-Activated Lancet Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Contact-Activated Lancet Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Contact-Activated Lancet Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Contact-Activated Lancet Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Contact-Activated Lancet Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Contact-Activated Lancet Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Contact-Activated Lancet Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Contact-Activated Lancet Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Contact-Activated Lancet Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Contact-Activated Lancet Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. BD Basic Information, Contact-Activated Lancet Manufacturing Base, Sales Area and Its Competitors
Table 73. BD Contact-Activated Lancet Product Portfolios and Specifications
Table 74. BD Contact-Activated Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. BD Main Business
Table 76. BD Latest Developments
Table 77. Accu-Chek (Roche) Basic Information, Contact-Activated Lancet Manufacturing Base, Sales Area and Its Competitors
Table 78. Accu-Chek (Roche) Contact-Activated Lancet Product Portfolios and Specifications
Table 79. Accu-Chek (Roche) Contact-Activated Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Accu-Chek (Roche) Main Business
Table 81. Accu-Chek (Roche) Latest Developments
Table 82. OneTouch (LifeScan) Basic Information, Contact-Activated Lancet Manufacturing Base, Sales Area and Its Competitors
Table 83. OneTouch (LifeScan) Contact-Activated Lancet Product Portfolios and Specifications
Table 84. OneTouch (LifeScan) Contact-Activated Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. OneTouch (LifeScan) Main Business
Table 86. OneTouch (LifeScan) Latest Developments
Table 87. FreeStyle (Abbott) Basic Information, Contact-Activated Lancet Manufacturing Base, Sales Area and Its Competitors
Table 88. FreeStyle (Abbott) Contact-Activated Lancet Product Portfolios and Specifications
Table 89. FreeStyle (Abbott) Contact-Activated Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. FreeStyle (Abbott) Main Business
Table 91. FreeStyle (Abbott) Latest Developments
Table 92. Microlet Next (Ascensia) Basic Information, Contact-Activated Lancet Manufacturing Base, Sales Area and Its Competitors
Table 93. Microlet Next (Ascensia) Contact-Activated Lancet Product Portfolios and Specifications
Table 94. Microlet Next (Ascensia) Contact-Activated Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Microlet Next (Ascensia) Main Business
Table 96. Microlet Next (Ascensia) Latest Developments
Table 97. Terumo Basic Information, Contact-Activated Lancet Manufacturing Base, Sales Area and Its Competitors
Table 98. Terumo Contact-Activated Lancet Product Portfolios and Specifications
Table 99. Terumo Contact-Activated Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Terumo Main Business
Table 101. Terumo Latest Developments
Table 102. Genteel Basic Information, Contact-Activated Lancet Manufacturing Base, Sales Area and Its Competitors
Table 103. Genteel Contact-Activated Lancet Product Portfolios and Specifications
Table 104. Genteel Contact-Activated Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Genteel Main Business
Table 106. Genteel Latest Developments
Table 107. CareTouch Basic Information, Contact-Activated Lancet Manufacturing Base, Sales Area and Its Competitors
Table 108. CareTouch Contact-Activated Lancet Product Portfolios and Specifications
Table 109. CareTouch Contact-Activated Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. CareTouch Main Business
Table 111. CareTouch Latest Developments
Table 112. Pip Diabetes Care Basic Information, Contact-Activated Lancet Manufacturing Base, Sales Area and Its Competitors
Table 113. Pip Diabetes Care Contact-Activated Lancet Product Portfolios and Specifications
Table 114. Pip Diabetes Care Contact-Activated Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Pip Diabetes Care Main Business
Table 116. Pip Diabetes Care Latest Developments
Table 117. Owen Mumford Basic Information, Contact-Activated Lancet Manufacturing Base, Sales Area and Its Competitors
Table 118. Owen Mumford Contact-Activated Lancet Product Portfolios and Specifications
Table 119. Owen Mumford Contact-Activated Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Owen Mumford Main Business
Table 121. Owen Mumford Latest Developments
Table 122. Trividia Health Basic Information, Contact-Activated Lancet Manufacturing Base, Sales Area and Its Competitors
Table 123. Trividia Health Contact-Activated Lancet Product Portfolios and Specifications
Table 124. Trividia Health Contact-Activated Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Trividia Health Main Business
Table 126. Trividia Health Latest Developments
Table 127. AUVON Basic Information, Contact-Activated Lancet Manufacturing Base, Sales Area and Its Competitors
Table 128. AUVON Contact-Activated Lancet Product Portfolios and Specifications
Table 129. AUVON Contact-Activated Lancet Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. AUVON Main Business
Table 131. AUVON Latest Developments
LIST OF FIGURES
Figure 1. Picture of Contact-Activated Lancet
Figure 2. Contact-Activated Lancet Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Contact-Activated Lancet Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Contact-Activated Lancet Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Contact-Activated Lancet Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Contact-Activated Lancet Sales Market Share by Country/Region (2025)
Figure 10. Contact-Activated Lancet Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Below 30G
Figure 12. Product Picture of Above 30G
Figure 13. Global Contact-Activated Lancet Sales Market Share by Type in 2026
Figure 14. Global Contact-Activated Lancet Revenue Market Share by Type (2021-2026)
Figure 15. Contact-Activated Lancet Consumed in Hospital
Figure 16. Global Contact-Activated Lancet Market: Hospital (2021-2026) & (K Units)
Figure 17. Contact-Activated Lancet Consumed in Clinic
Figure 18. Global Contact-Activated Lancet Market: Clinic (2021-2026) & (K Units)
Figure 19. Contact-Activated Lancet Consumed in Others
Figure 20. Global Contact-Activated Lancet Market: Others (2021-2026) & (K Units)
Figure 21. Global Contact-Activated Lancet Sale Market Share by Application (2025)
Figure 22. Global Contact-Activated Lancet Revenue Market Share by Application in 2026
Figure 23. Contact-Activated Lancet Sales by Company in 2026 (K Units)
Figure 24. Global Contact-Activated Lancet Sales Market Share by Company in 2026
Figure 25. Contact-Activated Lancet Revenue by Company in 2026 ($ millions)
Figure 26. Global Contact-Activated Lancet Revenue Market Share by Company in 2026
Figure 27. Global Contact-Activated Lancet Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Contact-Activated Lancet Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Contact-Activated Lancet Sales 2021-2026 (K Units)
Figure 30. Americas Contact-Activated Lancet Revenue 2021-2026 ($ millions)
Figure 31. APAC Contact-Activated Lancet Sales 2021-2026 (K Units)
Figure 32. APAC Contact-Activated Lancet Revenue 2021-2026 ($ millions)
Figure 33. Europe Contact-Activated Lancet Sales 2021-2026 (K Units)
Figure 34. Europe Contact-Activated Lancet Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Contact-Activated Lancet Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Contact-Activated Lancet Revenue 2021-2026 ($ millions)
Figure 37. Americas Contact-Activated Lancet Sales Market Share by Country in 2026
Figure 38. Americas Contact-Activated Lancet Revenue Market Share by Country (2021-2026)
Figure 39. Americas Contact-Activated Lancet Sales Market Share by Type (2021-2026)
Figure 40. Americas Contact-Activated Lancet Sales Market Share by Application (2021-2026)
Figure 41. United States Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Contact-Activated Lancet Sales Market Share by Region in 2026
Figure 46. APAC Contact-Activated Lancet Revenue Market Share by Region (2021-2026)
Figure 47. APAC Contact-Activated Lancet Sales Market Share by Type (2021-2026)
Figure 48. APAC Contact-Activated Lancet Sales Market Share by Application (2021-2026)
Figure 49. China Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 53. India Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Contact-Activated Lancet Sales Market Share by Country in 2026
Figure 57. Europe Contact-Activated Lancet Revenue Market Share by Country (2021-2026)
Figure 58. Europe Contact-Activated Lancet Sales Market Share by Type (2021-2026)
Figure 59. Europe Contact-Activated Lancet Sales Market Share by Application (2021-2026)
Figure 60. Germany Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 61. France Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Contact-Activated Lancet Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Contact-Activated Lancet Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Contact-Activated Lancet Sales Market Share by Application (2021-2026)
Figure 68. Egypt Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Contact-Activated Lancet in 2026
Figure 74. Manufacturing Process Analysis of Contact-Activated Lancet
Figure 75. Industry Chain Structure of Contact-Activated Lancet
Figure 76. Channels of Distribution
Figure 77. Global Contact-Activated Lancet Sales Market Forecast by Region (2027-2032)
Figure 78. Global Contact-Activated Lancet Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Contact-Activated Lancet Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Contact-Activated Lancet Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Contact-Activated Lancet Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Contact-Activated Lancet Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Contact-Activated Lancet
Figure 2. Contact-Activated Lancet Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Contact-Activated Lancet Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Contact-Activated Lancet Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Contact-Activated Lancet Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Contact-Activated Lancet Sales Market Share by Country/Region (2025)
Figure 10. Contact-Activated Lancet Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Below 30G
Figure 12. Product Picture of Above 30G
Figure 13. Global Contact-Activated Lancet Sales Market Share by Type in 2026
Figure 14. Global Contact-Activated Lancet Revenue Market Share by Type (2021-2026)
Figure 15. Contact-Activated Lancet Consumed in Hospital
Figure 16. Global Contact-Activated Lancet Market: Hospital (2021-2026) & (K Units)
Figure 17. Contact-Activated Lancet Consumed in Clinic
Figure 18. Global Contact-Activated Lancet Market: Clinic (2021-2026) & (K Units)
Figure 19. Contact-Activated Lancet Consumed in Others
Figure 20. Global Contact-Activated Lancet Market: Others (2021-2026) & (K Units)
Figure 21. Global Contact-Activated Lancet Sale Market Share by Application (2025)
Figure 22. Global Contact-Activated Lancet Revenue Market Share by Application in 2026
Figure 23. Contact-Activated Lancet Sales by Company in 2026 (K Units)
Figure 24. Global Contact-Activated Lancet Sales Market Share by Company in 2026
Figure 25. Contact-Activated Lancet Revenue by Company in 2026 ($ millions)
Figure 26. Global Contact-Activated Lancet Revenue Market Share by Company in 2026
Figure 27. Global Contact-Activated Lancet Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Contact-Activated Lancet Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Contact-Activated Lancet Sales 2021-2026 (K Units)
Figure 30. Americas Contact-Activated Lancet Revenue 2021-2026 ($ millions)
Figure 31. APAC Contact-Activated Lancet Sales 2021-2026 (K Units)
Figure 32. APAC Contact-Activated Lancet Revenue 2021-2026 ($ millions)
Figure 33. Europe Contact-Activated Lancet Sales 2021-2026 (K Units)
Figure 34. Europe Contact-Activated Lancet Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Contact-Activated Lancet Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Contact-Activated Lancet Revenue 2021-2026 ($ millions)
Figure 37. Americas Contact-Activated Lancet Sales Market Share by Country in 2026
Figure 38. Americas Contact-Activated Lancet Revenue Market Share by Country (2021-2026)
Figure 39. Americas Contact-Activated Lancet Sales Market Share by Type (2021-2026)
Figure 40. Americas Contact-Activated Lancet Sales Market Share by Application (2021-2026)
Figure 41. United States Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Contact-Activated Lancet Sales Market Share by Region in 2026
Figure 46. APAC Contact-Activated Lancet Revenue Market Share by Region (2021-2026)
Figure 47. APAC Contact-Activated Lancet Sales Market Share by Type (2021-2026)
Figure 48. APAC Contact-Activated Lancet Sales Market Share by Application (2021-2026)
Figure 49. China Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 53. India Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Contact-Activated Lancet Sales Market Share by Country in 2026
Figure 57. Europe Contact-Activated Lancet Revenue Market Share by Country (2021-2026)
Figure 58. Europe Contact-Activated Lancet Sales Market Share by Type (2021-2026)
Figure 59. Europe Contact-Activated Lancet Sales Market Share by Application (2021-2026)
Figure 60. Germany Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 61. France Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Contact-Activated Lancet Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Contact-Activated Lancet Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Contact-Activated Lancet Sales Market Share by Application (2021-2026)
Figure 68. Egypt Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Contact-Activated Lancet Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Contact-Activated Lancet in 2026
Figure 74. Manufacturing Process Analysis of Contact-Activated Lancet
Figure 75. Industry Chain Structure of Contact-Activated Lancet
Figure 76. Channels of Distribution
Figure 77. Global Contact-Activated Lancet Sales Market Forecast by Region (2027-2032)
Figure 78. Global Contact-Activated Lancet Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Contact-Activated Lancet Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Contact-Activated Lancet Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Contact-Activated Lancet Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Contact-Activated Lancet Revenue Market Share Forecast by Application (2027-2032)
